Pfizer’s Tukysa wins FDA approval for first-line maintenance treatment of HER2-positive metastatic breast cancer. buff.ly/0cr2xSG
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31194/pfizer-s-tukysa-approved-first-line-her2-breast-cancer